Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50-mg Film-Coated Tablet

Clin Pharmacol Drug Dev. 2017 May;6(3):313-317. doi: 10.1002/cpdd.275. Epub 2016 Jun 28.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anticonvulsants / administration & dosage*
  • Anticonvulsants / adverse effects
  • Anticonvulsants / blood
  • Anticonvulsants / pharmacokinetics*
  • Biological Availability
  • Cross-Over Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pyrrolidinones / administration & dosage*
  • Pyrrolidinones / adverse effects
  • Pyrrolidinones / blood
  • Pyrrolidinones / pharmacokinetics*
  • Solutions
  • Tablets
  • Therapeutic Equivalency
  • Young Adult

Substances

  • Anticonvulsants
  • Pyrrolidinones
  • Solutions
  • Tablets
  • brivaracetam